Treatment with infliximab for a child with Behçet's disease.
Saulsbury
Frank T
FT
Division of Immunology and Rheumatology, Department of Pediatrics, Box 800386, University of Virginia Health System, Charlottesville, VA 22908, USA.
Mann
James A
JA
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000188:drug therapy*; D002648:Child; D006801:Humans; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis / Q000187:drug effects
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab